Tau and β-amyloid are associated with medial temporal lobe structure, function, and memory encoding in normal aging

Journal of Neuroscience

Volumn 37, Issue 12, 2017, Pages 3192-3201

  Marks, Shawn M ^a   Lockhart, Samuel N ^a   Baker, Suzanne L ^b   Jagust, William J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Amyloid; Episodic memory; FMRI; Hippocampus; PET; Tau

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN; MAPT PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR ASSESSMENT; BRAIN ATROPHY; COGNITIVE AGING; FEMALE; HUMAN; HUMAN EXPERIMENT; LONGITUDINAL STUDY; MALE; MEDIAL TEMPORAL LOBE; MEMORY; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN AGGREGATION; TEMPORAL LOBE; ADOLESCENT; AGING; ANATOMY AND HISTOLOGY; EPISODIC MEMORY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; AMYLOID BETA-PEPTIDES; FEMALE; HUMANS; MALE; MEMORY, EPISODIC; MIDDLE AGED; TAU PROTEINS; TEMPORAL LOBE; YOUNG ADULT;

EID: 85016047612     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3769-16.2017     Document Type: Article

References (71)

1. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT (1992) Neuro-fibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42:631-639.
2. Bakker A, Kirwan CB, Miller M, Stark CE (2008) Pattern separation in the human hippocampal CA3 and dentate gyrus. Science 319:1640-1642.
3. Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, Yassa MA, Bassett SS, Shelton AL, Gallagher M (2012) Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron 74:467-474.
4. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, Wilson RS (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837-1844.
5. Bennett IJ, Huffman DJ, Stark CE (2015) Limbic tract integrity contributes to pattern separation performance across the lifespan. Cereb Cortex 25: 2988-2999.
6. Bero AW, Yan P, Roh JH, Cirrito JR, Stewart FR, Raichle ME, Lee JM, Holtz-man DM (2011) Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci 14:750-756.
7. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259.
8. Braak H, Braak E (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18:351-357.
9. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O (2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer’s disease. Science 321:1686-1689.
10. Cabeza R, Daselaar SM, Dolcos F, Prince SE, Budde M, Nyberg L (2004) Task-independent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval. Cereb Cortex 14:364-375.
11. Chabrier MA, Blurton-Jones M, Agazaryan AA, Nerhus JL, Martinez-Coria H, LaFerla FM (2012) Soluble Aβ promotes wild-type tau pathology in vivo. J Neurosci 32:17345-17350.
12. Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, Lee JH, Ryu YH, Lee MS, Lyoo CH (2016) In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol 80:247-258.
13. Cirrito JR, May PC, O’Dell MA, Taylor JW, Parsadanian M, Cramer JW, Audia JE, Nissen JS, Bales KR, Paul SM, DeMattos RB, Holtzman DM (2003) In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life. J Neurosci 23:8844-8853.
14. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-β levels in vivo. Neuron 48:913-922.
15. Crary JF, et al. (2014) Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol 128:755-766.
16. Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9:179-194.
17. Dennis NA, Hayes SM, Prince SE, Madden DJ, Huettel SA, Cabeza R (2008) Effects of aging on the neural correlates of successful item and source memory encoding. J Exp Psychol Learn Mem Cogn 34:791-808.
18. Duverne S, Motamedinia S, Rugg MD (2009) The relationship between aging, performance, and the neural correlates of successful memory encoding. Cereb Cortex 19:733-744.
19. Duvernoy HM (2005) The human hippocampus. Berlin: Springer.
20. Eklund A, Nichols TE, Knutsson H (2016) Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates. Proc Natl Acad Sci U S A 113:7900-7905.
21. Elman JA, Oh H, Madison CM, Baker SL, Vogel JW, Marks SM, Crowley S, O’Neil JP, Jagust WJ (2014) Neural compensation in older people with brain amyloid-β deposition. Nat Neurosci 17:1316-1318.
22. Fischl B, Liu A, Dale AM (2001) Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 20:70-80.
23. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, van der Kouwe A, Killiany R, Kennedy D, Klaveness S, Montillo A, Makris N, Rosen B, Dale AM (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341-355.
24. Fonov VS, Evans AC, McKinstry RC, Almli CR, Collins DL (2009) Unbiased nonlinear average age-appropriate brain templates from birth to adult-hood. Hum Brain Mapp 47:S102.
25. Hedden T, Gabrieli JD (2004) Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 5:87-96.
26. Huijbers W, Mormino EC, Wigman SE, Ward AM, Vannini P, McLaren DG, Becker JA, Schultz AP, Hedden T, Johnson KA, Sperling RA (2014) Amyloid deposition is linked to aberrant entorhinal activity among cognitively normal older adults. J Neurosci 34:5200-5210.
27. Huijbers W, Mormino EC, Schultz AP, Wigman S, Ward AM, Larvie M, Amariglio RE, Marshall GA, Rentz DM, Johnson KA, Sperling RA (2015) Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. Brain 138:1023-1035.
28. Hynd MR, Scott HL, Dodd PR (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochem Int 45:583-595.
29. Insausti R, Juottonen K, Soininen H, Insausti AM, Partanen K, Vainio P, Laakso MP, Pitkänen A (1998) MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neurora-diol 19:659-671.
30. Jernigan TL, Archibald SL, Berhow MT, Sowell ER, Foster DS, Hesselink JR (1991) Cerebral structure on MRI, part I: localization of age-related changes. Biol Psychiatry 29:55-67.
31. Johnson KA, et al. (2016) Tau positron emission tomographic imaging in aging and early Alzheimer disease. Ann Neurol 79:110-119.
32. Kennedy KM, Rodrigue KM, Devous MD Sr, Hebrank AC, Bischof GN, Park DC (2012) Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan. Neuroimage 62:1-8.
33. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H (1996) Hippocampal volumes in Alzheimer“s disease, Parkinson”s disease with and without dementia, and in vascular dementia: an MRI study. Neurology 46:678-681.
34. Logan J (2000) Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol 27:661-670.
35. Marr D (1971) Simple memory: a theory for archicortex. Philos Trans R Soc Lond B Biol Sci 262:23-81.
36. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A (1993) Correction for head size in brain-imaging measurements. Psychiatry Res Neuroim-aging 50:121-139.
37. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
38. Miller SL, Celone K, DePeau K, Diamond E, Dickerson BC, Rentz D, Pihla-jamäki M, Sperling RA (2008) Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation. Proc Natl Acad Sci U S A 105:2181-2186.
39. Mormino EC, Smiljic A, Hayenga AO, Onami SH, Greicius MD, Rabinovici GD, Janabi M, Baker SL, Yen IV, Madison CM, Miller BL, Jagust WJ (2011) Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex 21:2399-2407.
40. Mormino EC, Brandel MG, Madison CM, Marks S, Baker SL, Jagust WJ (2012) Aβ deposition in aging is associated with increases in brain activation during successful memory encoding. Cereb Cortex 22:1813-1823.
41. Ong WY, Tanaka K, Dawe GS, Ittner LM, Farooqui AA (2013) Slow excite-toxicity in Alzheimer’s disease. J Alzheimers Dis 35:643-668.
42. O’Reilly RC, Norman KA (2002) Hippocampal and neocortical contributions to memory: advances in the complementary learning systems framework. Trends Cogn Sci 6:505-510.
43. Ossenkoppele R, Schonhaut DR, Schöll M, Lockhart SN, Ayakta N, Baker SL, O’Neil JP, Janabi M, Lazaris A, Cantwell A, Vogel J, Santos M, Miller ZA, Bettcher BM, Vossel KA, Kramer JH, Gorno-Tempini ML, Miller BL, Jagust WJ, Rabinovici GD (2016) Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain 139:1551-1567.
44. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Bien-Ly N, Yoo J, Ho KO, Yu GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007) Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:697-711.
45. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25:1528-1547.
46. Price JL, Morris JC (1999) Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann Neurol 45:358-368.
47. Pruessner JC, Collins DL, Pruessner M, Evans AC (2001) Age and gender predict volume decline in the anterior and posterior hippocampus in early adulthood. J Neurosci 21:194-200.
48. Pruessner JC, Köhler S, Crane J, Pruessner M, Lord C, Byrne A, Kabani N, Collins DL, Evans AC (2002) Volumetry of temporopolar, perirhinal, entorhinal and parahippocampal cortex from high-resolution MR images: considering the variability of the collateral sulcus. Cereb Cortex 12:1342-1353.
49. Putcha D, Brickhouse M, O’Keefe K, Sullivan C, Rentz D, Marshall G, Dick-erson B, Sperling R (2011) Hippocampal hyperactivation associated with cortical thinning in Alzheimer’s disease signature regions in non-demented elderly adults. J Neurosci 31:17680-17688.
50. Raz N, Rodrigue KM, Head D, Kennedy KM, Acker JD (2004) Differential aging of the medial temporal lobe. Neurology 62:433-438.
51. Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, Wu T, Hamto P, Devidze N, Yu GQ, Palop JJ, Noebels JL, Mucke L (2011) Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer’s disease. J Neurosci 31:700-711.
52. Rousset OG, Ma Y, Evans AC (1998) Correction for partial volume effects in PET: principle and validation. J Nucl Med 39:904-911.
53. Scheltens PH (2001) Structural neuroimaging of Alzheimer’s disease and other dementias. Aging (Milano) 13:203-209.
54. Schöll M, Lockhart SN, Schonhaut DR, O’Neil JP, Janabi M, Ossenkoppele R, Baker SL, Vogel JW, Faria J, Schwimmer HD, Rabinovici GD, Jagust WJ (2016) PET imaging of tau deposition in the aging human brain. Neuron 89:971-982.
55. Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD Sr, Mintun MS (2016) Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histo-pathological stages. Brain 139:1539-1550.
56. Ségonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, Fischl B (2004) A hybrid approach to the skull stripping problem in MRI. Neuroimage 22:1060-1075.
57. Small SA, Stern Y, Tang M, Mayeux R (1999) Selective decline in memory function among healthy elderly. Neurology 52:1392-1396.
58. Sperling RA, Bates JF, Chua EF, Cocchiarella AJ, Rentz DM, Rosen BR, Schacter DL, Albert MS (2003) fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. J Neurol Neu-rosurg Psychiatry 74:44-50.
59. Sperling RA, Laviolette PS, O’Keefe K, O’Brien J, Rentz DM, Pihlajamaki M, Marshall G, Hyman BT, Selkoe DJ, Hedden T, Buckner RL, Becker JA, Johnson KA (2009) Amyloid deposition is associated with impaired de-fault network function in older persons without dementia. Neuron 63: 178-188.
60. Spires-Jones TL, Hyman BT (2014) The intersection of amyloid beta and tau at synapses in Alzheimer’s disease. Neuron 82:756-771.
61. Stanley DP, Shetty AK (2004) Aging in the rat hippocampus is associated with widespread reductions in the number of glutamate decarboxylase-67 positive interneurons but not interneuron degeneration. J Neurochem 89:204-216.
62. Thal DR, Rub U, Orantes M, Braak H (2002) Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
63. Treves A, Rolls ET (1994) Computational analysis of the role of the hippocampus in memory. Hippocampus 4:374-391.
64. van Rossum IA, Visser PJ, Knol DL, van der Flier WM, Teunissen CE, Barkhof F, Blankenstein MA, Scheltens P (2012) Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer’s disease. J Alzheimers Dis 29:319-327.
65. Vannini P, Hedden T, Becker JA, Sullivan C, Putcha D, Rentz D, Johnson KA, Sperling RA (2012) Age and amyloid-related alterations in default network habituation to stimulus repetition. Neurobiol Aging 33:1237-1252.
66. Vela J, Gutierrez A, Vitorica J, Ruano D (2003) Rat hippocampal GABAergic molecular markers are differentially affected by ageing. J Neurochem 85:368-377.
67. Villeneuve S, et al. (2015) Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation. Brain 138:2020-2033.
68. Xia CF, Arteaga J, Chen G, Gangadharmath U, Gomez LF, Kasi D, Lam C, Liang Q, Liu C, Mocharla VP, Mu F, Sinha A, Su H, Szardenings AK, Walsh JC, Wang E, Yu C, Zhang W, Zhao T, Kolb HC (2013) [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease. Alzheimers Dement 9:666-676.
69. Yassa MA, Muftuler LT, Stark CE (2010a) Ultrahigh-resolution microstructural diffusion tensor imaging reveals perforant path degradation in aged humans in vivo. Proc Natl Acad Sci U S A 107:12687-12691.
70. Yassa MA, Stark SM, Bakker A, Albert MS, Gallagher M, Stark CE (2010b) High-resolution structural and functional MRI of hippocampal CA3 and dentate gyrus in patients with amnestic mild cognitive impairment. Neu-roimage 51:1242-1252.
71. Yassa MA, Lacy JW, Stark SM, Albert MS, Gallagher M, Stark CE (2011) Pattern separation deficits associated with increased hippocampal CA3 and dentate gyrus activity in nondemented older adults. Hippocampus 21:968-979.